Specific, irreversible inactivation of the epidermal growth factor receptor and ErB2 by a new class of tyrosine kinase inhibitor. - Sherwood,V.; Bridges,A.J.; Denny,W.A. (Proc Am Assoc Cancer Res, 1999)